Seoulin Bioscience Co.,Ltd.

Equities

A038070

KR7038070009

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-02 pm EDT			5-day change	1st Jan Change
8,770 ^KRW	+0.11%		+0.69%	-4.67%

Mar. 20	Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022

March 15, 2023 at 04:16 am EDT

Seoulin Bioscience Co.,Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was KRW 91.49 million compared to KRW 304.1 million a year ago. Net income was KRW 9,541.54 million compared to KRW 15,589.41 million a year ago.

Basic earnings per share from continuing operations was KRW 1,109.6549 compared to KRW 1,871.2421 a year ago. Diluted earnings per share from continuing operations was KRW 890.3932. Basic earnings per share was KRW 1,112.5148 compared to KRW 1,815.1056 a year ago.

Diluted earnings per share was KRW 893.2531 compared to KRW 1,815.1056 a year ago.

Latest news about Seoulin Bioscience Co.,Ltd.

Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20	CI
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-15	CI
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Seoulin Bioscience Co.,Ltd.(KOSDAQ:A038070) dropped from S&P Global BMI Index	22-09-19	CI
Light Farm Tech Co., Ltd. announced that it has received KRW 1.999995 billion in funding from Seoulin Bioscience Co.,Ltd.	22-08-07	CI
Light Farm Tech Co., Ltd. announced that it expects to receive KRW 1.999995 billion in funding from Seoulin Bioscience Co.,Ltd. and other investors	22-07-21	CI
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-10	CI
Seoulin Bioscience Co.,Ltd. announced that it has received KRW 30 billion in funding from Shinhan Investment Corp., Investment Arm, Hanyang Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, Mirae Asset Capital Co,Ltd., Investment Arm, Cornerstone Investment Partners Co., Ltd., and other investors	21-11-23	CI
Seoulin Bioscience Co.,Ltd. announced that it expects to receive KRW 30 billion in funding from Shinhan Investment Corp., Investment Arm, Hanyang Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, Mirae Asset Capital Co,Ltd., Investment Arm, Cornerstone Investment Partners Co., Ltd., and other investors	21-11-21	CI
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-14	CI
Seoulin Bioscience Co.,Ltd.(KOSDAQ:A038070) added to S&P Global BMI Index	21-09-20	CI
Seoulin Bioscience Co.,Ltd.'s Equity Buyback announced on June 11, 2019, has expired.	20-06-11	CI
Tranche Update on Seoulin Bioscience Co.,Ltd.'s Equity Buyback Plan announced on August 8, 2019.	20-02-10	CI
Seoulin Bioscience Co.,Ltd.'s Equity Buyback announced on August 8, 2019, has expired with 92,246 shares, representing 1.2% for KRW 802.37 million.	20-02-07	CI
Seoulin Bioscience Co.,Ltd. announces an Equity Buyback for KRW 1,000 million worth of its shares.	19-08-08	CI
Seoulin Bioscience Co.,Ltd. authorizes a Buyback Plan.	19-08-07	CI
Seoulin Bioscience Co.,Ltd. announces an Equity Buyback for KRW 2,000 million worth of its shares.	19-06-10	CI
Seoulin Bioscience Co.,Ltd. authorizes a Buyback Plan.	19-06-10	CI
SeouLin Bioscience Co., Ltd. to Distribute Cellular Dynamics International, Inc.'s Products in Korea	15-08-20	CI

Chart Seoulin Bioscience Co.,Ltd.

Duration

Period

More charts

Company Profile

Seoulin Bioscience Co., Ltd is a Korea-based company engaged in the developing and manufacturing of basic equipment for bio research. The Company mainly engages in research and development of reagents, such as deoxyribonucleic acid (DNA) chips, which are used for gene therapy, clinical diagnosis, organs transplantation and biopsy; stem cells, which are used for treatment of incurable diseases, Alzheimer disease and others, and next-generation biotechnology drugs. The company supplies its products under the brand name MyLab. It also imports bio research equipment from Thermo Fisher, Affymetrix, Sarstedt and others, and markets in the domestic market. In addition, the Company engages in the real estate rental business.

Sector

Biotechnology & Medical Research

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
SEOULIN BIOSCIENCE CO.,LTD.	-4.67%	54.68M
MODERNA, INC.	+25.69%	48.09B
LONZA GROUP AG	+46.90%	40.62B
IQVIA HOLDINGS INC.	-3.46%	40.43B
CELLTRION, INC.	-6.20%	28.36B
ICON PUBLIC LIMITED COMPANY	+9.17%	24.89B
ALNYLAM PHARMACEUTICALS, INC.	-20.42%	19.01B
MEDPACE HOLDINGS, INC.	+28.07%	12.09B
BIO-TECHNE CORPORATION	+0.17%	11.88B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.24%	11.8B

Other Biotechnology & Medical Research